Saphnelo

Generic name: Anifrolumab-fnia
Dosage form: injection, for intravenous use
Drug class: Selective immunosuppressants

Usage of Saphnelo

Saphnelo infusion is a prescription medicine used for moderate to severe systemic lupus erythematosus (SLE or lupus) in adults who are also receiving other lupus medicines. Saphnelo (anifrolumab-fnia) works to reduce the body's immune and inflammatory response, to improve symptoms of SLE. Saphnelo is a monoclonal antibody that works by blocking type I interferon (INF-1) receptors.

SLE is an autoimmune disease that causes pain and inflammation in your body. It is caused by your body’s immune system attacking healthy tissue instead of only fighting infections. Often SLE patients have elevated type I interferon stimulation which means too many unnecessary interferon signals are getting through, leading to inflammation in different parts of the body. Saphnelo blocks INF-1 receptors in the immune system, which decreases inflammatory signals and so improves the symptoms of SLE and reduces lupus flares.

Saphnelo is not recommended for severe active lupus nephritis or severe active central nervous system lupus and is not approved for use by anyone younger than 18 years old

Saphnelo infusion was FDA approved on July 30, 2021.

Saphnelo side effects

Common side effects of Saphnelo may include:

upper respiratory infections

infusion reactions

cough

bronchitis

shingles (herpes zoster)

Saphnelo may cause serious side effects, including:

Serious Infections. This medicine can lower the ability of your immune system to fight infections. You may be at a higher risk of developing respiratory infections and shingles (herpes zoster) during treatment. Infections could be serious, leading to hospitalization or death. Tell your healthcare provider right away if you have any of the following symptoms of an infection:

fever, sweating, or chills

muscle aches

cough

shortness of breath

burning when urinating

urinating more often

diarrhea or stomach pain

warm, red, or painful skin or sores on your body.

Allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen during or after you get your infusion. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of a serious allergic reaction:

swelling of your face, mouth, and tongue

fainting or dizziness

breathing problems

feeling lightheaded (low blood pressure)

Cancer. Saphnelo may reduce the activity of your immune system. Medicines that affect the immune system may increase your risk of certain cancers.

These are not all of the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Saphnelo

You should not use Saphnelo if you are allergic to the active ingredient anifrolumab-fnia or any of the inactive ingredients in the injection. There is a complete list of ingredients at the bottom of this page.

Before you receive Saphnelo it is important to tell your healthcare provider about all of your medical conditions, especially if you:

may have an infection or have infections that keep coming back. If you have an infection you should not receive Saphnelo unless your doctor or other healthcare provider tells you to. See Side Effects section below for a list of infection symptoms.

have or have had any type of cancer as there is an increased risk of cancer with the use of immunosuppressants.

are receiving other biologic medicines or monoclonal antibodies.

Make sure you are up to date on all vaccines before you start using this medicine. You should not receive live vaccines during treatment with Saphnelo.

Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant as it is not known if Saphnelo will harm your unborn baby.

Saphnelo may affect your baby's immune system, but having SLE during pregnancy may cause complications such as worsened lupus, dangerously high blood pressure (eclampsia), premature birth, miscarriage, or growth problems in the unborn baby. SLE in the mother may also cause lupus or heart problems to develop in the newborn. The benefit of treating SLE may outweigh any risks to the baby.

Pregnancy Exposure Registry. A pregnancy exposure registry monitors pregnancy outcomes in women who have used this medicine. You can find out more information about the Saphnelo pregnancy registry by calling AstraZeneca at 1-877-693-9268.

Breastfeeding

If you are breastfeeding or planning to breastfeed while on Saphnelo you should talk to your healthcare professional, as it is not known if this medicine passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while receiving this medicine.

Relate drugs

How to use Saphnelo

Usual Saphnelo Adult Dose for Systemic Lupus Erythematosus:

300 mg intravenous infusion given over 30 minutes every 4 weeks.

Available as 300 mg/2 mL (150 mg/mL) single-dose vial.

Comment:

This medicine is not recommended for patients with severe active lupus nephritis or severe active central nervous system lupus as the efficacy in these patients has not been evaluated.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your injection.

If a planned infusion of this medicine is missed, it should be given as soon as possible, but maintain a minimum interval of 14 days between infusions.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What other drugs will affect Saphnelo

Many drugs can interact with Saphnelo, and some drugs should not be used at the SAMe time. Tell your doctor about all other medicines you use. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.